WordNet

limit, block, or decrease the action or function of; "inhibit the action of the enzyme"; "inhibit the rate of a chemical reaction"
control and refrain from showing; of emotions, desires, impulses, or behavior (同)bottle up, suppress
limit the range or extent of; "Contact between the young was inhibited by strict social customs"
the organic process of synthesizing and releasing some substance (同)secernment
a functionally specialized substance (especially one that is not a waste) released from a gland or cell
a substance that retards or stops an activity

PrepTutorEJDIC

〈感情・欲望・行動・作用など〉‘を'抑制する / (…しないように)〈人〉‘を'抑制する,妨げる《+『名』+『from』+『名』(do『ing』)》
〈C〉分泌(ぶんぴつ)作用(過程) / 〈C〉分泌物 / 〈U〉(…を)隠すこと《+『of』+『名』》
抑制する人(物) / 化学反応抑制剤

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. プロトンポンプ阻害薬：胃酸分泌が関与する疾患への使用と副作用の概要proton pump inhibitors overview of use and adverse effects in the treatment of acid related disorders [show details]
… Proton pump inhibitors (PPIs) effectively block gastric acid secretion by irreversibly binding to and inhibiting the hydrogen-potassium ATPase pump that resides on the luminal surface of the parietal …
2. 止血の概要overview of hemostasis [show details]
… (endogenous) inhibitors of the coagulation pathways are: Tissue factor pathway – tissue factor pathway inhibitor (TFPI) Contact activation pathway – C1 esterase inhibitor (C1-inh) TFPI… matrix; Aggregation – Platelet-platelet cohesion; Secretion – The release of platelet granule proteins; Procoagulant…
3. 胃酸分泌の生理学physiology of gastric acid secretion [show details]
… Acid secretion is tightly controlled by a second hormone, somatostatin, which is a potent inhibitor of both gastrin and histamine synthesis and release, and, therefore, of gastric acid secretion. Gastrin …
4. 副甲状腺ホルモンの分泌および作用parathyroid hormone secretion and action [show details]
…stimulating intestinal calcium absorption as well as bone turnover. Calcitriol feeds back to inhibit PTH secretion indirectly through its calcemic action, as well as by exerting a direct inhibitory action …
5. 抗利尿ホルモン不適合分泌（SIADH）症候群の病態生理および病因pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion siadh [show details]
… ADH secretion. Similarly, a minor increase in blood pressure or blood volume caused by saline infusion results in a large decrease in ADH secretion . In addition to the persistent secretion of ADH… derivative of carbamazepine), high-dose intravenous cyclophosphamide, and selective serotonin reuptake inhibitors . Experimental studies suggest that chlorpropamide may increase concentrating ability both by …

English Journal

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.

Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, Gaze D, Kiotsekoglou A, Yuan L, Hu J, Foley C, Van Dyck L, Knight R, Clayton T, Swan L, Thomson JDR, Erdem G, Crossman D, Flather M, .
Lancet (London, England). 2020 Dec;394(10216)2263-2270.
Irbesartan, a long acting selective angiotensin-1 receptor inhibitor, in Marfan syndrome might reduce aortic dilatation, which is associated with dissection and rupture. We aimed to determine the effects of irbesartan on the rate of aortic dilatation in children and adults with Marfan syndrome. We d
PMID 31836196

Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles.

Liu N, Ji J, Qiu H, Shao Z, Wen X, Chen A, Yao S, Zhang X, Yao H, Zhang L.
Artificial cells, nanomedicine, and biotechnology. 2020 Dec;48(1)305-314.
Combining DNA damage repair inhibitors and chemotherapeutic agents is an emerging strategy in cancer treatment. In this study, we engineered the polycation nanoparticle (NP), which co-encapsulated DNA damage repair inhibitor Dbait and chemotherapeutic drug Docetaxel (Dtxl), using H1 nanopolymer (fol
PMID 31858836